Advertisement
Screener

Savara Inc (SVRA) Foreign Currency Transaction Gain (Loss), before Tax

2.2 / 5 stars · 17/39 Roast Me

Savara Inc Foreign Currency Transaction Gain (Loss), before Tax

Savara Inc (SVRA) reported Foreign Currency Transaction Gain (Loss), before Tax of -$81.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Income Statement › Other Income

us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-08-11

  • Savara Inc foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was -$81.00K, a 168.64% decline year-over-year.
  • Savara Inc foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was -$216.00K, a 460.00% decline year-over-year.
  • Savara Inc foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was -$12.00K, a 105.53% decline year-over-year.
  • Savara Inc foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was $146.00K.
  • Savara Inc foreign currency transaction gain (loss), before tax for fiscal 2025 was $310.00K, a 507.84% increase from fiscal 2024.
  • Savara Inc foreign currency transaction gain (loss), before tax for fiscal 2024 was $51.00K, a 32.89% decline from fiscal 2023.
  • Savara Inc foreign currency transaction gain (loss), before tax for fiscal 2023 was $76.00K.
  • Savara Inc foreign currency transaction gain (loss), before tax for fiscal 2022 was -$19.00K.
Period endForeign Currency Transaction Gain (Loss), before Tax 3 monthForeign Currency Transaction Gain (Loss), before Tax 6 monthForeign Currency Transaction Gain (Loss), before Tax 9 monthForeign Currency Transaction Gain (Loss), before Tax 12 month
2026-06-30-$81.00K
10-Q · filed 2026-08-11
-$297.00K
10-Q · filed 2026-08-11
-$309.00K
derived: sum of 3 quarters · filed 2026-08-11
-$163.00K
derived: sum of 4 quarters · filed 2026-08-11
2026-03-31-$216.00K
10-Q · filed 2026-05-12
-$228.00K
derived: sum of 2 quarters · filed 2026-05-12
-$82.00K
derived: sum of 3 quarters · filed 2026-05-12
$36.00K
derived: sum of 4 quarters · filed 2026-08-11
2025-12-31-$12.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13
$134.00K
derived: sum of 2 quarters · filed 2026-03-13
$252.00K
derived: sum of 3 quarters · filed 2026-08-11
$310.00K
10-K · filed 2026-03-13
2025-09-30$146.00K
10-Q · filed 2025-11-12
$264.00K
derived: sum of 2 quarters · filed 2026-08-11
$322.00K
10-Q · filed 2025-11-12
$541.00K
derived: sum of 4 quarters · filed 2026-08-11
2025-06-30$118.00K
10-Q · filed 2026-08-11
$176.00K
10-Q · filed 2026-08-11
$395.00K
derived: sum of 3 quarters · filed 2026-08-11
$375.00K
derived: sum of 4 quarters · filed 2026-08-11
2025-03-31$60.00K
10-Q · filed 2026-05-12
$277.00K
derived: sum of 2 quarters · filed 2026-05-12
$257.00K
derived: sum of 3 quarters · filed 2026-05-12
$132.00K
derived: sum of 4 quarters · filed 2026-05-12
2024-12-31$217.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13
$197.00K
derived: sum of 2 quarters · filed 2026-03-13
$72.00K
derived: sum of 3 quarters · filed 2026-03-13
$51.00K
10-K · filed 2026-03-13
2024-09-30-$20.00K
10-Q · filed 2025-11-12
-$145.00K
derived: sum of 2 quarters · filed 2025-11-12
-$166.00K
10-Q · filed 2025-11-12
-$154.00K
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30-$125.00K
10-Q · filed 2025-08-13
-$146.00K
10-Q · filed 2025-08-13
-$134.00K
derived: sum of 3 quarters · filed 2025-08-13
-$133.00K
derived: sum of 4 quarters · filed 2025-08-13
2024-03-31-$21.00K
10-Q · filed 2025-05-13
-$9.00K
derived: sum of 2 quarters · filed 2025-05-13
-$8.00K
derived: sum of 3 quarters · filed 2025-05-13
$25.00K
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31$12.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27
$13.00K
derived: sum of 2 quarters · filed 2025-03-27
$46.00K
derived: sum of 3 quarters · filed 2025-03-27
$76.00K
10-K · filed 2025-03-27
2023-09-30$1.00K
10-Q · filed 2024-11-12
$34.00K
derived: sum of 2 quarters · filed 2024-11-12
$64.00K
10-Q · filed 2024-11-12
$23.00K
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30$33.00K
10-Q · filed 2024-08-12
$62.00K
10-Q · filed 2024-08-12
$22.00K
derived: sum of 3 quarters · filed 2024-08-12
$14.00K
derived: sum of 4 quarters · filed 2024-08-12
2023-03-31$29.00K
10-Q · filed 2024-05-09
-$11.00K
derived: sum of 2 quarters · filed 2024-05-09
-$19.00K
derived: sum of 3 quarters · filed 2024-05-09
$23.00K
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31-$40.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07
-$48.00K
derived: sum of 2 quarters · filed 2024-03-07
-$6.00K
derived: sum of 3 quarters · filed 2024-03-07
-$19.00K
10-K · filed 2024-03-07
2022-09-30-$8.00K
10-Q · filed 2023-11-09
$34.00K
derived: sum of 2 quarters · filed 2023-11-09
$21.00K
10-Q · filed 2023-11-09
-$56.00K
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$42.00K
10-Q · filed 2023-08-10
$29.00K
10-Q · filed 2023-08-10
-$48.00K
derived: sum of 3 quarters · filed 2023-08-10
-$56.00K
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31-$13.00K
10-Q · filed 2023-05-15
-$90.00K
derived: sum of 2 quarters · filed 2023-05-15
-$98.00K
derived: sum of 3 quarters · filed 2023-05-15
-$55.00K
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31-$77.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30
-$85.00K
derived: sum of 2 quarters · filed 2023-03-30
-$42.00K
derived: sum of 3 quarters · filed 2023-03-30
-$99.00K
10-K · filed 2023-03-30
2021-09-30-$8.00K
10-Q · filed 2022-11-10
$35.00K
derived: sum of 2 quarters · filed 2022-11-10
-$22.00K
10-Q · filed 2022-11-10
-$218.00K
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$43.00K
10-Q · filed 2022-08-11
-$15.00K
10-Q · filed 2022-08-11
-$210.00K
derived: sum of 3 quarters · filed 2022-08-11
-$62.00K
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31-$57.00K
10-Q · filed 2022-05-11
-$253.00K
derived: sum of 2 quarters · filed 2022-05-11
-$105.00K
derived: sum of 3 quarters · filed 2022-05-11
-$55.00K
derived: sum of 4 quarters · filed 2022-05-11
2020-12-31-$196.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30
-$48.00K
derived: sum of 2 quarters · filed 2022-03-30
$2.00K
derived: sum of 3 quarters · filed 2022-03-30
$158.00K
10-K · filed 2022-03-30
2020-09-30$148.00K
10-Q · filed 2021-11-12
$198.00K
derived: sum of 2 quarters · filed 2021-11-12
$354.00K
10-Q · filed 2021-11-12
$109.00K
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30$50.00K
10-Q · filed 2021-08-12
$206.00K
10-Q · filed 2021-08-12
-$39.00K
derived: sum of 3 quarters · filed 2021-08-12
$77.00K
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31$156.00K
10-Q · filed 2021-05-13
-$89.00K
derived: sum of 2 quarters · filed 2021-05-13
$27.00K
derived: sum of 3 quarters · filed 2021-05-13
$137.00K
derived: sum of 4 quarters · filed 2021-05-13
2019-12-31-$245.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10
-$129.00K
derived: sum of 2 quarters · filed 2021-03-10
-$19.00K
derived: sum of 3 quarters · filed 2021-03-10
-$78.00K
10-K · filed 2021-03-10
2019-09-30$116.00K
10-Q · filed 2020-11-05
$226.00K
derived: sum of 2 quarters · filed 2020-11-05
$167.00K
10-Q · filed 2020-11-05
$151.00K
derived: sum of 4 quarters · filed 2020-11-05
2019-06-30$110.00K
10-Q · filed 2020-08-06
$51.00K
10-Q · filed 2020-08-06
$35.00K
derived: sum of 3 quarters · filed 2020-08-06
$28.00K
derived: sum of 4 quarters · filed 2020-08-06
2019-03-31-$59.00K
10-Q · filed 2020-05-07
-$75.00K
derived: sum of 2 quarters · filed 2020-05-07
-$82.00K
derived: sum of 3 quarters · filed 2020-05-07
$73.00K
derived: sum of 4 quarters · filed 2020-05-07
2018-12-31-$16.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12
-$23.00K
derived: sum of 2 quarters · filed 2020-03-12
$132.00K
derived: sum of 3 quarters · filed 2020-03-12
$71.00K
10-K · filed 2020-03-12
2018-09-30-$7.00K
10-Q · filed 2019-11-07
$148.00K
derived: sum of 2 quarters · filed 2019-11-07
$87.00K
10-Q · filed 2019-11-07
$94.00K
derived: sum of 4 quarters · filed 2019-11-07
2018-06-30$155.00K
10-Q · filed 2019-08-08
$94.00K
10-Q · filed 2019-08-08
$101.00K
derived: sum of 3 quarters · filed 2019-08-08
$30.00K
derived: sum of 4 quarters · filed 2019-08-08
2018-03-31-$61.00K
10-Q · filed 2019-05-09
-$54.00K
derived: sum of 2 quarters · filed 2019-05-09
-$125.00K
derived: sum of 3 quarters · filed 2019-05-09
-$247.00K
derived: sum of 4 quarters · filed 2019-05-09
2017-12-31$7.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13
-$64.00K
derived: sum of 2 quarters · filed 2019-03-13
-$186.00K
derived: sum of 3 quarters · filed 2019-03-13
-$218.00K
10-K · filed 2019-03-13
2017-09-30-$71.00K
10-Q · filed 2018-11-07
-$193.00K
derived: sum of 2 quarters · filed 2018-11-07
-$225.00K
10-Q · filed 2018-11-07
-$321.00K
derived: sum of 4 quarters · filed 2018-11-07
2017-06-30-$122.00K
10-Q · filed 2018-08-09
-$154.00K
10-Q · filed 2018-08-09
-$250.00K
derived: sum of 3 quarters · filed 2018-08-09
-$158.00K
derived: sum of 4 quarters · filed 2018-08-09
2017-03-31-$32.00K
10-Q · filed 2018-05-09
-$128.00K
derived: sum of 2 quarters · filed 2018-05-09
-$36.00K
derived: sum of 3 quarters · filed 2018-05-09
2016-12-31-$96.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14
-$4.00K
derived: sum of 2 quarters · filed 2018-03-14
-$76.00K
10-K · filed 2018-03-14
2016-09-30$92.00K
10-Q · filed 2017-11-08
$20.00K
10-Q · filed 2017-11-08
2016-06-30-$72.00K
10-Q · filed 2017-08-09
2013-12-31$1.00K
10-K · filed 2014-03-26
2012-12-31$53.00K
10-K · filed 2014-03-26
2011-12-31$11.00K
10-K · filed 2013-03-19

Similar stocks

Stock NameCountryMarket CapPE Ratio
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
MANNKIND CORP (MNKD)United States$1.058B-30.41
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
Corvus Pharmaceuticals, Inc. (CRVS)United States$0.994B-23.25
Amphastar Pharmaceuticals, Inc. (AMPH)United States$1.116B10.93
Kura Oncology, Inc. (KURA)United States$0.967B-3.29
Arbutus Biopharma Corp (ABUS)$0.965B6.19
Seaport Therapeutics, Inc. (SPTX)United States$1.131B